
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy
Lianyi Yang, Yazhen Wang, Yujun Song, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 354-366
Closed Access | Times Cited: 12
Lianyi Yang, Yazhen Wang, Yujun Song, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 354-366
Closed Access | Times Cited: 12
Showing 12 citing articles:
Carrier-free nanoparticles for cancer theranostics with dual-mode magnetic resonance imaging/fluorescence imaging and combination photothermal and chemodynamic therapy
Yuhan Ding, Caiting Deng, Yuchen Yang, et al.
International Journal of Pharmaceutics (2025), pp. 125285-125285
Closed Access | Times Cited: 3
Yuhan Ding, Caiting Deng, Yuchen Yang, et al.
International Journal of Pharmaceutics (2025), pp. 125285-125285
Closed Access | Times Cited: 3
Biometallic ions and derivatives: a new direction for cancer immunotherapy
Lin Zhao, Yajun Gui, Jing Cai, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Lin Zhao, Yajun Gui, Jing Cai, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Immunomodulatory metal-based biomaterials for cancer immunotherapy
Kangzhi Yuan, Cai Zhang, Xiang-Ying Pan, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 249-268
Closed Access | Times Cited: 5
Kangzhi Yuan, Cai Zhang, Xiang-Ying Pan, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 249-268
Closed Access | Times Cited: 5
Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy
Sheng‐Liang Cheng, H.T. Lee, Chung‐Pin Li, et al.
ACS Nano (2024) Vol. 18, Iss. 43, pp. 29439-29456
Open Access | Times Cited: 4
Sheng‐Liang Cheng, H.T. Lee, Chung‐Pin Li, et al.
ACS Nano (2024) Vol. 18, Iss. 43, pp. 29439-29456
Open Access | Times Cited: 4
Facile integration of a binary nano-prodrug with αPD-L1 as a translatable technology for potent immunotherapy of TNBC
Zongtao Zhou, Fuchun Guo, Jinyan Zhang, et al.
Acta Biomaterialia (2025)
Closed Access
Zongtao Zhou, Fuchun Guo, Jinyan Zhang, et al.
Acta Biomaterialia (2025)
Closed Access
Modified probiotics and the related combinatorial therapeutics
Luo Zhao, Mengya Niu, Ziqian Ma, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Luo Zhao, Mengya Niu, Ziqian Ma, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Dual-modality immune nano-activator harnessing Mn2⁺ and quercetin to potentiate the cGAS-STING pathway for advanced cancer metalloimmunotherapy
Shanshan Ma, Xuequan Zhang, Xiaoqi Zhu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Shanshan Ma, Xuequan Zhang, Xiaoqi Zhu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Discovery of Airway-Administered Ionophores for Mn2+ to Mitigate Lung Metastasis by Targeting Disseminated Tumor Cell
Yuming Wang, Ni Fan, Rui Wang, et al.
ACS Nano (2025)
Closed Access
Yuming Wang, Ni Fan, Rui Wang, et al.
ACS Nano (2025)
Closed Access
Manganese-Doped Nanoparticles with Hypoxia-Inducible Factor 2α Inhibitor That Elicit Innate Immune Responses against von Hippel–Lindau Protein-Deficient Tumors
Fang Yan, Feiyang Shen, Rui Huang, et al.
ACS Nano (2025)
Closed Access
Fang Yan, Feiyang Shen, Rui Huang, et al.
ACS Nano (2025)
Closed Access
Manganese-Based Nanotherapeutics for Targeted Treatment of Breast Cancer
Mubassir Khan, Razi Ullah, Syed Nisar Hussain Shah, et al.
ACS Applied Bio Materials (2025)
Closed Access
Mubassir Khan, Razi Ullah, Syed Nisar Hussain Shah, et al.
ACS Applied Bio Materials (2025)
Closed Access
Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy
M. Zhang, Yifan Zhao, Bai Lv, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 36, pp. 47270-47283
Closed Access | Times Cited: 1
M. Zhang, Yifan Zhao, Bai Lv, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 36, pp. 47270-47283
Closed Access | Times Cited: 1
Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy
Lipeng Zhu, Dongliang Leng, Ziang Guo, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 524-539
Closed Access
Lipeng Zhu, Dongliang Leng, Ziang Guo, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 524-539
Closed Access
“Convex Lens” of DNA damage: A nanomedicine enhances anti-PD-1 immunotherapy as immunogenic cell death inducer for “cold” melanoma
Wenjun Wang, Yu Liu, Dong Chen, et al.
Nano Today (2024) Vol. 61, pp. 102598-102598
Closed Access
Wenjun Wang, Yu Liu, Dong Chen, et al.
Nano Today (2024) Vol. 61, pp. 102598-102598
Closed Access